SIRT1 and cancer: While the inclusion of estradiol replacement therapy appears to be a promising means of restoring SIRT1 expression and activity, at the same time, it also appears that estradiol shapes SIRT1 expression in cancer cells, which may lead to the unwanted progress of cancerogenesis and metastasis.